Bristol-Myers Squibb Company
Immunomodulators
Last updated:
Abstract:
The present disclosure provides compounds which are immunomodulators and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Status:
Grant
Type:
Utility
Filling date:
11 Dec 2019
Issue date:
14 Jun 2022